Biotech - Press Releases

Date	Title	Company
02-Aug-2020	Immunic, Inc. Reports Positive Top-line Data from Phase 2 EMPhASIS Trial of IMU-838 in Patients with Relapsing-Remitting Multiple Sclerosis	Immunic, Inc.
02-Aug-2020	Varian to Combine with Siemens Healthineers in $16.4 Billion All-Cash Transaction	Varian
31-Jul-2020	Coronavirus (COVID-19) Update: FDA Authorizes First Two Tests that Estimate a Patient's Antibodies from Past SARS-CoV-2 Infection	U.S. Food and Drug Administration
31-Jul-2020	Synlogic to Present at Upcoming Virtual Banking Conferences	Synlogic, Inc.
31-Jul-2020	ESSA Pharma Completes Public Offering for Aggregate Gross Proceeds of US$48,990,000	ESSA Pharma Inc
31-Jul-2020	Horizon Discovery Group plc Half Year Trading Update	Horizon Discovery Group plc
31-Jul-2020	Alliance for Regenerative Medicine Calls for Multi-Stakeholder Pan-European Initiative to Fast-Track Real World Evidence in Support of Patient Access to Advanced Therapies	The Alliance for Regenerative Medicine (ARM)
31-Jul-2020	Novadip Biosciences to Present at the LifeSci Partners Summer Symposium	Novadip Biosciences
31-Jul-2020	AMRYT TO HOST KEY OPINION LEADER CALL ON EPIDERMOLYSIS BULLOSA DISEASE LANDSCAPE	Amryt
31-Jul-2020	Enterome initiates first clinical trial with EO2401 – an innovative microbiome-antigen (‘OncoMimic’) based cancer immunotherapy candidate targeting aggressive brain cancer	Enterome
31-Jul-2020	Helsinn Advanced Synthesis opens its largest dedicated Anticancer bay	Helsinn Group
31-Jul-2020	Tagrisso granted Breakthrough Therapy Designation in the US for the adjuvant treatment of patients with Stage IB-IIIA EGFR-mutated lung cancer	AstraZeneca
31-Jul-2020	RedHill Biopharma Initiates Global Phase 2/3 Study for COVID-19	RedHill Biopharma
31-Jul-2020	Invitation to the Extraordinary Shareholders’ Meeting	Biocartis Group NV
31-Jul-2020	Oxford Biomedica Signs Three Year Clinical Supply Agreement with Axovant Gene Therapies for Manufacture and Supply of AXO-Lenti-PD	Oxford Biomedica
31-Jul-2020	Sanofi and GSK selected for Operation Warp Speed to supply United States government with 100 million doses of COVID-19 vaccine	Sanofi
31-Jul-2020	Breakthrough for pet health and sustainability	Veramaris V.O.F.
31-Jul-2020	BioNTech Announces Strategic Collaboration with Regeneron to Advance FixVac and Libtayo® (cemiplimab) Combination in Melanoma	BioNTech
31-Jul-2020	Combating Coronavirus Through Reversing Diabetes	The Diabetes Reversal Company
31-Jul-2020	Pfizer and BioNTech to Supply Japan with 120 Million Doses of Their BNT162 mRNA-Based Vaccine Candidate	Pfizer Inc